Director Walid Gellad Describes Challenges to Drug Pricing Policy

October 26, 2018

In a recent speech about drug pricing, President Trump described current problems impacting the issue, including the lack of a mechanism to lower prices in Medicare Part B. However, the administration did not outline clear solutions. In fact, as CP3 Director Walid Gellad writes in STAT, the obstacles in front of these solutions may be insurmountable from a number of perspectives. "Logistical challenges also threaten the success of the administration’s proposals," states Gellad. "Namely, there is no concrete plan, just a set of ideas with innumerable questions and uncertainties."